{"id":"W1997170706","doi":"10.1097/01.jto.0000284095.28451.43","title":"P3-120: Response rates of erlotinib or gefitinib compared to docetaxel as subsequent line therapy in advanced non-small cell lung cancer (NSCLC) in clinical practice","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Docetaxel; Medicine; Erlotinib; Gefitinib; Oncology; Internal medicine; Lung cancer; Chemotherapy; Erlotinib Hydrochloride; Progression-free survival; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00223075,0.0002897307,0.001365194,0.0002924449,0.0001794727,0.0005257239,0.0004203642,0.001287236,0.002214988],"category_scores_gemma":[0.005010474,0.000213667,0.001250808,0.0004971914,0.0002800176,0.0006227155,0.0002237679,0.001140185,0.0004424149],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006914628,"about_ca_system_score_gemma":0.0005652819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001555184,"about_ca_topic_score_gemma":0.001853533,"domain_scores_codex":[0.9990073,0.0004298453,0.0001052478,0.0001892607,0.0001380131,0.0001303531],"domain_scores_gemma":[0.9972868,0.00143167,0.0006013198,0.0001177116,0.0001471967,0.0004152778],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6314204,0.004774565,0.1510878,0.0003937407,0.00127508,0.0003818875,0.000324298,0.002559393,0.0121248,0.0001489183,0.003107816,0.1924013],"study_design_scores_gemma":[0.03995221,0.1456007,0.7863048,0.00007663397,0.002955395,0.002171132,0.0002086193,0.008304004,0.01162873,0.0003109018,0.002415575,0.0000712719],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975581,0.001109109,0.00007815329,0.0001923199,0.00001466033,0.00003635842,0.0003039815,0.00001893862,0.0006884092],"genre_scores_gemma":[0.9991899,0.0001892525,0.00007791121,0.00006805783,0.00002046839,0.00001923829,0.0002054749,0.000007317088,0.0002223628],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00223075,"threshold_uncertainty_score":0.01179749,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0665285186272268,"score_gpt":0.555089055594481,"score_spread":0.4885605369672542,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}